Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.
about
Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practice.Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis.Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients.Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report.
P2860
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Non-classic EGFR mutations in ...... following EGFR-TKI treatment.
@en
Non-classic EGFR mutations in ...... following EGFR-TKI treatment.
@nl
type
label
Non-classic EGFR mutations in ...... following EGFR-TKI treatment.
@en
Non-classic EGFR mutations in ...... following EGFR-TKI treatment.
@nl
prefLabel
Non-classic EGFR mutations in ...... following EGFR-TKI treatment.
@en
Non-classic EGFR mutations in ...... following EGFR-TKI treatment.
@nl
P2093
P2860
P356
P1476
Non-classic EGFR mutations in ...... s following EGFR-TKI treatment
@en
P2093
D A M Heideman
E Thunnissen
J L Kuiper
K Grünberg
P E Postmus
P J F Snijders
S M S Hashemi
P2860
P2888
P304
P356
10.1038/BJC.2016.372
P407
P577
2016-11-22T00:00:00Z